February the 18th, 2025 – Croatia is now on track to begin producing medicine from human plasma once again from 2030 onwards.

Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...

More than half of your blood is comprised of plasma. Donating plasma is a longer process than donating blood. Human plasma is used to produce therapies that treat disease. How much you'll make for ...

With no synthetic substitute for plasma, drug manufacturers rely on a steady stream of human donors to make up their supply. Treating just one patient with plasma therapies for a year takes ...

At the Human Amyloid Imaging (HAI) meeting, held January 15-17, researchers focused on new techniques—all based on tau and ...